Orchestra BioMed Holdings reported a gross margin of 71.59% and a net margin of -27,362.50% for the quarter ended Jun 2026. These financial ratios cover 23 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||
| Gross Margin | 95.15% | 85.04% | 95.18% | 95.19% | 96.22% | 94.10% | 90.21% | 82.06% | 94.52% | 94.34% | 93.11% | 77.08% | 94.93% | 94.50% | 94.31% | 99.84% | 70.91% | 71.59% | |||||
| EBT Margin | -592.15% | -1,903.74% | -865.61% | -891.02% | -991.84% | -1,415.96% | -3,247.97% | -4,340.84% | -2,162.42% | -2,051.03% | -1,562.92% | -6,385.38% | -2,160.71% | -2,316.15% | -2,419.05% | 19.38% | -20,815.45% | -27,413.64% | |||||
| EBIT Margin | -592.15% | -1,903.74% | -865.61% | -891.02% | -991.84% | -1,415.96% | -3,466.35% | -4,763.74% | -2,326.29% | -2,166.97% | -1,655.72% | -6,591.70% | -2,179.84% | -2,311.84% | -2,359.23% | 21.85% | -20,069.09% | -25,404.55% | |||||
| EBITDA Margin | -592.15% | -1,903.74% | -865.61% | -891.02% | -991.84% | -1,415.96% | -3,466.35% | -4,763.74% | -2,314.35% | -2,157.46% | -1,648.02% | -6,558.50% | -2,170.28% | -2,302.15% | -2,349.83% | 21.85% | -20,069.09% | -25,404.55% | |||||
| Operating Margin | -592.15% | -1,903.74% | -865.61% | -891.02% | -991.84% | -1,415.96% | -3,466.35% | -4,763.74% | -2,326.29% | -2,166.97% | -1,655.72% | -6,591.70% | -2,179.84% | -2,311.84% | -2,359.23% | 21.85% | -20,069.09% | -25,404.55% | |||||
| Net Margin | -592.15% | -1,903.74% | -865.61% | -891.02% | -991.84% | -1,415.96% | -3,247.97% | -4,340.84% | -2,162.42% | -2,051.03% | -1,562.92% | -6,385.38% | -2,160.71% | -2,316.15% | -2,419.05% | 19.38% | -18,778.18% | -27,362.50% | |||||
| FCF Margin | -620.21% | -2,052.62% | -643.16% | -797.64% | -1,238.49% | -1,149.40% | -2,458.47% | -4,187.40% | -2,132.42% | -1,312.85% | -1,394.93% | -5,392.89% | -1,927.19% | -1,861.36% | -1,725.90% | -7.45% | -20,320.00% | -22,256.82% | |||||
| Efficiency | |||||||||||||||||||||||
| Inventory AverageInventory Avg. | 0.25M | 0.20M | 0.16M | 0.14M | 0.13M | 0.09M | 0.15M | 0.20M | 0.15M | 0.16M | 0.28M | 0.34M | 0.29M | 0.26M | |||||||||
| Assets AverageAssets Avg. | 161.96M | 161.85M | 161.68M | 161.55M | 115.12M | 82.11M | 115.93M | 131.08M | 121.12M | 105.78M | 88.92M | 77.51M | 73.85M | 75.75M | 67.61M | 50.94M | 73.82M | 109.83M | 107.76M | 108.18M | |||
| Invested CapitalInvested Cap. | -19.63M | 64.11M | 109.28M | 99.00M | 89.25M | 47.25M | 31.20M | 14.68M | 57.94M | 67.84M | 55.52M | 33.72M | |||||||||||
| Asset Utilization RatioAsset Util. | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.03 | 0.04 | 0.03 | 0.04 | 0.06 | 0.04 | 0.30 | 0.30 | 0.30 | ||||||||
| Leverage & Solvency | |||||||||||||||||||||||
| Debt Ratio | 0.00 | 0.12 | 0.07 | 0.08 | 0.08 | 0.19 | 0.24 | 0.34 | 0.14 | 0.12 | 0.14 | 0.12 | |||||||||||
| Valuation | |||||||||||||||||||||||
| Price to EarningsP/E | -0.00M | -0.00M | -39.52 | -26.68 | -13.49 | -16.68 | -53.80 | -19.31 | -22.90 | -28.72 | -14.07 | -18.30 | -12.64 | -9.46 | -8.74 | -5.35 | -6.72 | 39.51 | -12.06 | -10.78 | |||
| Price to SalesP/S | 234.02 | 507.94 | 116.81 | 148.62 | 533.65 | 273.44 | 743.88 | 0.00M | 304.17 | 375.28 | 197.60 | 603.86 | 188.91 | 123.88 | 162.64 | 7.66 | 0.00M | 0.00M | |||||
| Price to BookP/B | -52.48 | -10.42 | 0.00M | 2.93 | 2.21 | 3.12 | 6.23 | 2.80 | 3.91 | 4.80 | 3.30 | 6.62 | 4.22 | 4.64 | 9.73 | 351.07 | 3.20 | 4.42 | 6.05 | 13.44 | |||
| Enterprise Value | 200.47M | 204.38M | 201.24M | 202.38M | 135.12M | 17.45M | 386.16M | 34.35M | 118.89M | 185.05M | 79.19M | 196.57M | 99.15M | 51.43M | 92.25M | 64.07M | 12.27M | 90.06M | 116.03M | 75.22M | |||
| EV to EBIT | -0.00M | -0.00M | -39.24 | -26.51 | -13.42 | -1.78 | -33.45 | -2.65 | -8.19 | -14.83 | -5.49 | -11.66 | -6.07 | -3.08 | -4.88 | -3.31 | -0.60 | 13.33 | -5.26 | -3.36 | |||
| EV to EBITDA | -0.00M | -0.00M | -39.24 | -26.51 | -13.42 | -1.78 | -33.45 | -2.65 | -8.19 | -14.83 | -5.52 | -11.71 | -6.10 | -3.10 | -4.90 | -3.33 | -0.61 | 13.33 | -5.26 | -3.36 | |||
| Market Capitalization | 202.25M | 206.14M | 202.66M | 203.68M | 135.85M | 163.93M | 621.17M | 250.20M | 311.69M | 326.65M | 188.59M | 291.97M | 195.03M | 152.78M | 163.98M | 103.56M | 140.03M | 236.69M | 249.18M | 259.65M | |||
| Price to FCFP/FCF | -0.00M | -0.01M | -37.73 | -24.75 | -18.16 | -18.63 | -43.09 | -23.79 | -30.26 | -29.77 | -14.26 | -28.59 | -14.17 | -11.20 | -9.80 | -6.66 | -9.42 | -102.77 | -11.15 | -13.26 | |||
| EV to FCF | -0.00M | -0.01M | -37.47 | -24.59 | -18.06 | -1.98 | -26.79 | -3.27 | -11.54 | -16.87 | -5.99 | -19.25 | -7.20 | -3.77 | -5.51 | -4.12 | -0.83 | -39.11 | -5.19 | -3.84 | |||
| EV to CFO | -0.00M | -0.01M | -37.80 | -25.41 | -18.62 | -2.00 | -26.85 | -3.27 | -11.56 | -16.86 | -6.04 | -19.26 | -7.24 | -3.80 | -5.55 | -4.13 | -0.84 | -39.67 | -5.23 | -3.89 | |||
| Return Ratios | |||||||||||||||||||||||
| Return on Sales [ROS]ROS | -592.15% | -1,903.74% | -865.61% | -891.02% | -991.84% | -1,415.96% | -3,466.35% | -4,763.74% | -2,326.29% | -2,166.97% | -1,655.72% | -6,591.70% | -2,179.84% | -2,311.84% | -2,359.23% | 21.85% | -20,069.09% | -25,404.55% | |||||
| Return on Capital Employed [ROCE]ROCE | -0.24% | -3.35% | -8.07% | -20.16% | -51.39% | -37.62% | -37.24% | -49.03% | -54.46% | -69.28% | -92.52% | -104.29% | -108.00% | -131.99% | -210.37% | -141.53% | -55.65% | -58.43% | -61.23% | ||||
| Return on Assets [ROA]ROA | -0.24% | -3.35% | -8.01% | -19.91% | -39.77% | -33.71% | -33.87% | -39.58% | -46.78% | -57.74% | -70.12% | -76.05% | -80.46% | -98.05% | -136.83% | -101.74% | -48.21% | -52.99% | -57.18% |